MedPath

ALCON RESEARCH

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Nepafenac Once Daily for Macular Edema - Study 2

Phase 3
Completed
Conditions
Non-Proliferative Diabetic Retinopathy
Cataract
Interventions
Other: Vehicle
First Posted Date
2013-06-07
Last Posted Date
2016-08-02
Lead Sponsor
Alcon Research
Target Recruit Count
819
Registration Number
NCT01872611

Lid Wiper Epitheliopathy Trial

Not Applicable
Terminated
Conditions
Lid Wiper Epitheliopathy
Interventions
Device: Etafilcon A contact lenses
Device: Spectacles
Device: Delefilcon A contact lenses
First Posted Date
2013-06-06
Last Posted Date
2014-10-29
Lead Sponsor
Alcon Research
Target Recruit Count
187
Registration Number
NCT01870856

Clinical Evaluation of Systane® ULTRA Compared to OPTIVE® in Ocular Surface Staining

Not Applicable
Completed
Conditions
Dry Eye Syndrome
Interventions
Other: Preservative-free saline solution eyedrops
Other: Systane® ULTRA lubricant eyedrops
Other: OPTIVE® lubricating eyedrops
First Posted Date
2013-05-27
Last Posted Date
2015-08-04
Lead Sponsor
Alcon Research
Target Recruit Count
105
Registration Number
NCT01863368

Pharmacokinetic Evaluation of Moxifloxacin in Vigadexa® in Aqueous Humor Samples Following Preoperative Antibiotic/Steroid Dosing in Cataract Surgery Patients

Phase 4
Completed
Conditions
Cataract
Interventions
First Posted Date
2013-05-22
Last Posted Date
2013-08-07
Lead Sponsor
Alcon Research
Target Recruit Count
36
Registration Number
NCT01859702

Visual Performance Investigation of Two Toric Soft Contact Lenses

Not Applicable
Completed
Conditions
Refractive Error
Myopia
Astigmatism
Hyperopia
Interventions
Device: Lotrafilcon B toric contact lens
Device: Comfilcon A toric contact lens
First Posted Date
2013-05-21
Last Posted Date
2014-10-22
Lead Sponsor
Alcon Research
Target Recruit Count
49
Registration Number
NCT01858701

Nepafenac Once Daily for Macular Edema - Study 1

Phase 3
Completed
Conditions
Non-Proliferative Diabetic Retinopathy
Cataract
Interventions
Other: Nepafenac vehicle
First Posted Date
2013-05-14
Last Posted Date
2016-08-03
Lead Sponsor
Alcon Research
Target Recruit Count
881
Registration Number
NCT01853072

ESBA1008 Microvolume Study

Phase 2
Completed
Conditions
Exudative Age-Related Macular Degeneration
Interventions
Drug: ESBA1008 solution
First Posted Date
2013-05-08
Last Posted Date
2016-03-24
Lead Sponsor
Alcon Research
Target Recruit Count
107
Registration Number
NCT01849692

Intra-Operative Metrics With CENTURION® and INFINITI® Vision Systems

Not Applicable
Completed
Conditions
Cataract
Interventions
Device: CENTURION® Vision System (CVS)
Device: INFINITI® Vision System (IVS)
First Posted Date
2013-05-07
Last Posted Date
2015-04-07
Lead Sponsor
Alcon Research
Target Recruit Count
112
Registration Number
NCT01848288

Subjective Comparison of Pre-Lens Tear Film Stability With Daily Disposable Contact Lenses

Not Applicable
Completed
Conditions
Myopia
Hyperopia
Refractive Error
Interventions
Device: Nelfilcon A contact lenses
Device: Etafilcon A contact lenses
Device: Omafilcon A contact lenses
First Posted Date
2013-04-24
Last Posted Date
2014-06-20
Lead Sponsor
Alcon Research
Target Recruit Count
30
Registration Number
NCT01839318

Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration

Phase 1
Completed
Conditions
Age-related Macular Degeneration
Interventions
First Posted Date
2013-04-18
Last Posted Date
2016-03-25
Lead Sponsor
Alcon Research
Target Recruit Count
50
Registration Number
NCT01835015
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy